David Henry

Summary

Affiliation: University of Newcastle
Country: Australia

Publications

  1. pmc Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials
    Paul A Carless
    School of Medical Practice and Population Health, Faculty of Health, University of Newcastle, New South Wales, Australia
    BMC Cardiovasc Disord 5:19. 2005
  2. ncbi request reprint Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry
    David Henry
    Discipline of Clinical Pharmacology, School of Medical Practice and Population Health, University of Newcastle, Callaghan, Australia
    Arch Intern Med 165:2493-6. 2005
  3. ncbi request reprint Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme
    David A Henry
    School of Medicine and Public Health, University of Newcastle, New South Wales, Australia
    JAMA 294:2630-2. 2005
  4. ncbi request reprint Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience
    David A Henry
    School of Medical Practice and Population Health, University of Newcastle, NSW
    Med J Aust 182:557-60. 2005
  5. pmc Cyclooxygenase-2 inhibitors and coronary occlusion--exploring dose-response relationships
    Patricia McGettigan
    Discipline of Clinical Pharmacology, School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia
    Br J Clin Pharmacol 62:358-65. 2006
  6. pmc Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases
    Patricia McGettigan
    Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia
    Br J Clin Pharmacol 65:927-34. 2008
  7. pmc Disease mongering is now part of the global health debate
    Ray Moynihan
    School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia
    PLoS Med 5:e106. 2008
  8. ncbi request reprint Moral hazard and prescription medicine use in Australia--the patient perspective
    Evan Doran
    Research Academic, Discipline of Clinical Pharmacology, The University of Newcastle, Level 5 CSB, Mater M Hospital, Waratah NSW 2298, Australia
    Soc Sci Med 60:1437-43. 2005
  9. ncbi request reprint Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia
    E Doran
    Discipline of Clinical Pharmacology, School of Medical Practice and Population Health, University of Newcastle, New South Wales, Australia
    Soc Sci Med 62:1510-9. 2006
  10. ncbi request reprint Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme
    Jane Robertson
    Clinical Pharmacology, School of Medicine and Public Health, The University of Newcastle, Waratah, NSW, Australia
    Int J Pharm Pract 18:88-92. 2010

Collaborators

Detail Information

Publications33

  1. pmc Are antifibrinolytic drugs equivalent in reducing blood loss and transfusion in cardiac surgery? A meta-analysis of randomized head-to-head trials
    Paul A Carless
    School of Medical Practice and Population Health, Faculty of Health, University of Newcastle, New South Wales, Australia
    BMC Cardiovasc Disord 5:19. 2005
    ..The lysine analogues tranexamic acid (TXA) and epsilon aminocaproic acid (EACA) are cheaper, but it is not known if they are as effective as aprotinin...
  2. ncbi request reprint Ties that bind: multiple relationships between clinical researchers and the pharmaceutical industry
    David Henry
    Discipline of Clinical Pharmacology, School of Medical Practice and Population Health, University of Newcastle, Callaghan, Australia
    Arch Intern Med 165:2493-6. 2005
    ..To quantify this relationship we conducted a survey of medical specialists listed in the Medical Directory of Australia in 2002 and 2003...
  3. ncbi request reprint Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme
    David A Henry
    School of Medicine and Public Health, University of Newcastle, New South Wales, Australia
    JAMA 294:2630-2. 2005
  4. ncbi request reprint Medical specialists and pharmaceutical industry-sponsored research: a survey of the Australian experience
    David A Henry
    School of Medical Practice and Population Health, University of Newcastle, NSW
    Med J Aust 182:557-60. 2005
    ..To characterise research relationships between medical specialists and the pharmaceutical industry in Australia...
  5. pmc Cyclooxygenase-2 inhibitors and coronary occlusion--exploring dose-response relationships
    Patricia McGettigan
    Discipline of Clinical Pharmacology, School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia
    Br J Clin Pharmacol 62:358-65. 2006
    ..To investigate the relationship between acute coronary syndrome (ACS) and ingested doses of selective cyclooxygenase-2 (COX-2) inhibitors and other nonsteroidal anti-inflammatory drugs (NSAIDs)...
  6. pmc Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases
    Patricia McGettigan
    Discipline of Clinical Pharmacology, School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia
    Br J Clin Pharmacol 65:927-34. 2008
    ..Recently published studies have found lower relative risk (RR) estimates than the initial studies published in 1998-2000. It is unclear whether the level of risk is elevated equally in first time and recurrent cases of CHF...
  7. pmc Disease mongering is now part of the global health debate
    Ray Moynihan
    School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia
    PLoS Med 5:e106. 2008
  8. ncbi request reprint Moral hazard and prescription medicine use in Australia--the patient perspective
    Evan Doran
    Research Academic, Discipline of Clinical Pharmacology, The University of Newcastle, Level 5 CSB, Mater M Hospital, Waratah NSW 2298, Australia
    Soc Sci Med 60:1437-43. 2005
    ..Prescription medicines did not appear as 'common goods' where subsidised access motivates a 'consumer' to demand more or make the prospect of prescription use more attractive or necessary...
  9. ncbi request reprint Empirical uncertainty and moral contest: a qualitative analysis of the relationship between medical specialists and the pharmaceutical industry in Australia
    E Doran
    Discipline of Clinical Pharmacology, School of Medical Practice and Population Health, University of Newcastle, New South Wales, Australia
    Soc Sci Med 62:1510-9. 2006
    ....
  10. ncbi request reprint Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme
    Jane Robertson
    Clinical Pharmacology, School of Medicine and Public Health, The University of Newcastle, Waratah, NSW, Australia
    Int J Pharm Pract 18:88-92. 2010
    ..The aim of the study was to assess the extent of pharmacist participation in pharmaceutical industry-sponsored educational events in Australia...
  11. ncbi request reprint Limitations of Health Insurance Commission (HIC) data for deriving prescribing indicators
    Jane Robertson
    Department of Clinical Pharmacology, School of Medical Practice and Population Health, University of Newcastle, NSW
    Med J Aust 176:419-24. 2002
    ....
  12. pmc An analysis of news media coverage of complementary and alternative medicine
    Billie Bonevski
    Discipline of Clinical Pharmacology, University of Newcastle, Newcastle, New South Wales, Australia
    PLoS ONE 3:e2406. 2008
    ..To examine the accuracy and adequacy of lay media news stories about complementary and alternative medicines and therapies...
  13. ncbi request reprint Transparency in pricing arrangements for medicines listed on the Australian Pharmaceutical Benefits Scheme
    Jane Robertson
    Clinical Pharmacology, University of Newcastle, Calvary Mater Hospital, Waratah, Newcastle, NSW 2298
    Aust Health Rev 33:192-9. 2009
    ..In some, the lack of transparency may have reflected the desire of manufacturers to disguise the true negotiated price, lest it weaken their negotiation position in other jurisdictions...
  14. ncbi request reprint Deconstructing cancer: what makes a good-quality news story?
    Amanda J Wilson
    School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia
    Med J Aust 193:702-6. 2010
    ..To describe an in-depth analysis of the content and quality of stories about new cancer interventions in Australian media...
  15. ncbi request reprint A Quality Use of Medicines program for general practitioners and older people: a cluster randomised controlled trial
    Sabrina W Pit
    School of Medical Practice and Public Health, Faculty of Health, University of Newcastle, Newcastle, New South Wales, Australia
    Med J Aust 187:23-30. 2007
    ..To investigate the effectiveness of an educational Quality Use of Medicines program, delivered at the level of general practice, on medicines use, falls and quality of life in people aged > or = 65 years...
  16. ncbi request reprint Effect of computerised prescribing on use of antibiotics
    David A Newby
    Department of Clinical Pharmacology, School of Medical Practice and Population Health, Faculty of Health, University of Newcastle, Newcastle Mater Misericordiae Hospital, Newcastle, NSW 2298, Australia
    Med J Aust 178:210-3. 2003
    ..To examine whether the use of current prescribing software systems might raise rates of repeat prescribing, with a consequent increase in use of antibiotics in the community...
  17. ncbi request reprint The influence of specialists on prescribing by GPs. A qualitative study
    Jane Robertson
    School of Medical Practice and Population Health, Faculty of Health, University of Newcastle, New South Wales
    Aust Fam Physician 32:573-6. 2003
    ..To investigate specialists' influence on prescribing by general practitioners...
  18. doi request reprint The affordability of prescription medicines in Australia: are copayments and safety net thresholds too high?
    Andrew Searles
    Hunter Medical Research Institute, The University of Newcastle, Hunter Valley Research Foundation, Australia
    Aust Health Rev 37:32-40. 2013
    ..To create and report survey-based indicators of the affordability of prescription medicines for patients in Australia...
  19. ncbi request reprint Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2
    Patricia McGettigan
    Discipline of Clinical Pharmacology, School of Medicine and Public Health, The University of Newcastle, New South Wales, Australia
    JAMA 296:1633-44. 2006
    ..Regulatory agencies have provided variable advice regarding the cardiovascular risks with older nonselective NSAIDs...
  20. pmc Media reporting of health interventions: signs of improvement, but major problems persist
    Amanda Wilson
    Discipline of Clinical Pharmacology, School of Medicine and Public Health, The University of Newcastle, Newcastle, Australia
    PLoS ONE 4:e4831. 2009
    ..This analysis of more than 1200 stories in the Australian media compares different types of media outlets and examines reporting trends over time...
  21. ncbi request reprint Reference pricing, generic drugs and proposed changes to the Pharmaceutical Benefits Scheme
    Andrew Searles
    School of Medicine and Public Health, University of Newcastle, Newcastle, NSW, Australia
    Med J Aust 187:236-9. 2007
    ..This is important, in view of growing evidence of the unaffordability of prescription medicines in the Australian community...
  22. pmc Describing treatment effects to patients
    Annette Moxey
    School of Medical Practice and Population Health, The University of Newcastle, Australia
    J Gen Intern Med 18:948-59. 2003
    ..To examine the impact of different presentations of equivalent information (framing) on treatment decisions faced by patients...
  23. pmc The fight against disease mongering: generating knowledge for action
    Ray Moynihan
    University of Newcastle, Newcastle, New South Wales, Australia
    PLoS Med 3:e191. 2006
  24. ncbi request reprint The pharmaceutical industry as a medicines provider
    David Henry
    School of Medical Practice and Population Health, Faculty of Health, University of Newcastle, New South Wales, Australia
    Lancet 360:1590-5. 2002
    ..Better access to essential drugs may be achieved through voluntary licensing arrangements between international pharmaceutical companies and manufacturers in developing countries...
  25. ncbi request reprint Patient co-payments and use of prescription medicines
    Evan Doran
    Clinical Pharmacology, School of Medical Practice and Population Health, Faculty of Health, University of Newcastle, Mater Hospital, Waratah, New South Wales
    Aust N Z J Public Health 28:62-7. 2004
    ..To investigate how prescription co-payments influence the medicine use of Australian patients...
  26. ncbi request reprint Cell salvage for minimising perioperative allogeneic blood transfusion
    Paul A Carless
    Discipline of Clinical Pharmacology, Faculty of Health, University of Newcastle, Level 5, Clinical Sciences Building, Newcastle Mater Hospital, Edith Street, Waratah, Newcastle, New South Wales, Australia, 2298
    Cochrane Database Syst Rev 3:CD001888. 2010
    ....
  27. ncbi request reprint The PBS community awareness campaign: how helpful is blaming patients?
    Evan Doran
    Discipline of Clinical Pharmacology, University of Newcastle, Newcastle, NSW, Australia
    Med J Aust 179:544-5. 2003
    ....
  28. ncbi request reprint Differential pricing of drugs: a role for cost-effectiveness analysis?
    Ruth Lopert
    WHO Collaborating Centre for Training in Pharmacology and Rational Drug Use, School of Medical Practice and Population Health, Faculty of Health, University of Newcastle, New South Wales, Australia
    Lancet 359:2105-7. 2002
    ..Indicative prices for drugs can be derived by cost-effectiveness analysis that incorporates a measure of national wealth. Such prices could be used internationally as a basis of differential price negotiations...
  29. ncbi request reprint Cell salvage for minimising perioperative allogeneic blood transfusion
    Paul A Carless
    Discipline of Clinical Pharmacology, Faculty of Health, University of Newcastle, Level 5, Clinical Sciences Building, Newcastle Mater Hospital, Edith Street, Waratah, Newcastle, New South Wales, Australia, 2298
    Cochrane Database Syst Rev 4:CD001888. 2010
    ....
  30. ncbi request reprint Drug advertising: truths, half-truths and few statistics
    David A Newby
    Med J Aust 177:285-6. 2002
  31. ncbi request reprint Bringing epidemiology into drug utilisation research
    Jacques Lelorier
    University of Montreal, Hôtel Dieu Centre de Recherche, 3850 Rue St Urbain, Montreal PQ H2W1T8, Canada
    Pharmacoepidemiol Drug Saf 12:153-6. 2003
  32. ncbi request reprint Evaluating medicines: let's use all the evidence
    Chris W Kelman
    National Centre for Epidemiology and Population Health and ANU Medical School, Australian National University, Canberra, ACT, Australia
    Med J Aust 186:249-52. 2007
    ..Australia is well placed to pilot such a model system...
  33. ncbi request reprint Monitoring the quality of medical news reporting: early experience with media doctor
    David E Smith
    South Lakes Medical Group, Dora Creek, NSW
    Med J Aust 183:190-3. 2005
    ..To analyse the reviews of medical news articles posted on media doctor, a medical news-story monitoring website...